MedPath

NECROtizing Soft Tissue Infections and Their Scoring System

Conditions
Necrosis
Registration Number
NCT05224817
Lead Sponsor
Methodist Health System
Brief Summary

Primary Objective:

The primary objective of this study is to develop and validate a clinical risk index score for identifying NSTIs in emergency general surgery patients being evaluated for a severe skin and soft tissue infection.

Secondary Objectives:

To describe the contemporary microbiology of NSTIs and explore the effects on outcomes and to identify predictors of amputation and mortality.

Detailed Description

This study is designed as a multicenter, prospective, observational study. There will be no direct interaction with subjects and involves no interventions; study is conducted completely via review of electronic health records. Our site will only collect data from the Methodist Dallas Medical Center. We plan to complete the data collection and analysis by 12/30/2021.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1010
Inclusion Criteria
  • All adult patients (age ≥18 years old and ≤89 years old) with suspected or confirmed NSTI
Exclusion Criteria
  • Age <18 years old and age > 89 years
  • Pregnancy
  • Prisoners
  • Below ankle diabetic foot infections complicated by peripheral vascular disease
  • Burn wounds

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the presence of necrosisup to 30 days

thrombosed vessels or absence of bleeding

mortality length of time in hospital30-90 days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Methodist Dallas Medical Center

🇺🇸

Dallas, Texas, United States

Methodist Dallas Medical Center
🇺🇸Dallas, Texas, United States
Michael Truitt, MD
Contact
214-947-2315
michaeltruitt@mhd.com
© Copyright 2025. All Rights Reserved by MedPath